Purvi Mehra

1.8k total citations
13 papers, 780 citations indexed

About

Purvi Mehra is a scholar working on Infectious Diseases, Clinical Biochemistry and Pharmacology. According to data from OpenAlex, Purvi Mehra has authored 13 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 5 papers in Clinical Biochemistry and 4 papers in Pharmacology. Recurrent topics in Purvi Mehra's work include Antimicrobial Resistance in Staphylococcus (6 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Drug-Induced Adverse Reactions (2 papers). Purvi Mehra is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (6 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Drug-Induced Adverse Reactions (2 papers). Purvi Mehra collaborates with scholars based in United States. Purvi Mehra's co-authors include Carisa De Anda, Anita Das, Philippe Prokocimer, Edward Fang, William O’Riordan, Laura Lawrence, Sue Cammarata, Samantha Good, Antonio L. Pérez and Greg Moeck and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Allergy and Clinical Immunology.

In The Last Decade

Purvi Mehra

13 papers receiving 754 citations

Peers

Countries citing papers authored by Purvi Mehra

Since Specialization

Citations

This map shows the geographic impact of Purvi Mehra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Purvi Mehra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Purvi Mehra more than expected).

Fields of papers citing papers by Purvi Mehra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Purvi Mehra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Purvi Mehra. The network helps show where Purvi Mehra may publish in the future.

Co-authorship network of co-authors of Purvi Mehra

This figure shows the co-authorship network connecting the top 25 collaborators of Purvi Mehra. A scholar is included among the top collaborators of Purvi Mehra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Purvi Mehra. Purvi Mehra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	A Randomized, Open-Label, Single-Dose Study to Assess Safety and Systemic Exposure of Triamcinolone Acetonide Extended-Release in Patients With Hip Osteoarthritis 2022 ·Rheumatology and Therapy ·Alan Kivitz, Purvi Mehra, P Hanson, Louis M. Kwong, Amy Çinar, Joelle Lufkin, Scott D. Kelley	4
2	Safety and Systemic Exposure of Triamcinolone Acetonide Following Ultrasound-Guided Intra-Articular Injection of Triamcinolone Extended-Release or Standard Triamcinolone Acetonide in Patients with Shoulder Osteoarthritis: An Open-Label, Randomized Study 2021 ·Drugs in R&D ·P Hanson, Alan Kivitz, Purvi Mehra, Louis M. Kwong, Amy Çinar, Joelle Lufkin, Scott D. Kelley	4
3	Efficacy and Safety of Tedizolid and Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Injection Drug Users: Analysis of Two Clinical Trials 2018 ·Infectious Diseases and Therapy ·Gregory J. Moran, Carisa De Anda, Anita Das, Sinikka Green, Purvi Mehra, Philippe Prokocimer	11
4	A randomized, double-blind, Phase 2 study to evaluate subjective and objective outcomes in patients with acute bacterial skin and skin structure infections treated with delafloxacin, linezolid or vancomycin 2015 ·Journal of Antimicrobial Chemotherapy ·(unknown), Purvi Mehra, Laura Lawrence, (unknown), Erin M. Duffy, Sue Cammarata, John Pullman	66
5	Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections 2014 ·New England Journal of Medicine ·G. Ralph Corey, Heidi Kabler, Purvi Mehra, Sandeep K. Gupta, J. Scott Overcash, Ashwin Porwal, Philip Giordano, Christopher Lucasti, Antonio L. Pérez, Samantha Good, Hai Jiang, Greg Moeck, William O’Riordan	226
6	A randomized phase 2 study comparing two doses of delafloxacin with tigecycline in adults with complicated skin and skin-structure infections 2014 ·International Journal of Infectious Diseases ·William O’Riordan, Purvi Mehra, (unknown), (unknown), Laura Lawrence, Sue Cammarata	86
7	Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections 2013 ·JAMA ·Philippe Prokocimer, Carisa De Anda, Edward Fang, Purvi Mehra, Anita Das	283
8	Idx184 in Combination with Pegylated Interferon-α2A and Ribavirin for 2 Weeks in Treatment-Naive Patients with Chronic Hepatitis C 2013 ·Antiviral Therapy ·Jacob Lalezari, Terry Box, William O’Riordan, Purvi Mehra, Tuan Nguyen, Fred Poordad, Edwin DeJesus, Paul Y. Kwo, Eliot Godofsky, (unknown), (unknown), Jie Chen, Joseph McCarville, Keith Pietropaolo, (unknown), J. Sullivan-Bolyai, Douglas L. Mayers	9
9	Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections 2013 ·Philippe Prokocimer, Carisa De Anda, Edward Fang, Purvi Mehra, Anita Das	3
10	A STUDY TO ASSESS SKIN LESION MEASUREMENT TECHNIQUES RELATED TO ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS 2012 ·Michael W. Dunne, Purvi Mehra, Sinikka Green, (unknown), (unknown), (unknown), George H. Talbot, Anita Das, Anna Maria Cattelan	3
11	Effect of leukotriene modifier drugs on the safety of oral aspirin challenges 2006 ·Annals of Allergy Asthma & Immunology ·Andrew A. White, Elizabeth Ludington, Purvi Mehra, Donald D. Stevenson, Ronald A. Simon	70
12	Dyspnea, wheezing, and airways obstruction: is it asthma? 2006 ·PubMed ·Purvi Mehra, Katharine M. Woessner	5
13	Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease 2005 ·Journal of Allergy and Clinical Immunology ·Donald D. Stevenson, Purvi Mehra, Andrew A. White, Sameer Gupta, (unknown), Ronald A. Simon	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact